Understanding variations in secondary findings reporting practices across U.S. genome sequencing laboratories

&
AJOB Empirical Bioethics 9 (1):48-57 (2018)
  Copy   BIBTEX

Abstract

This article has no associated abstract. (fix it)

Categories

Add categories

Keywords

Reprint years

DOI

10.1080/23294515.2017.1405095

Links

PhilArchive



    Upload a copy of this work     Papers currently archived: 91,881

External links

Setup an account with your affiliations in order to access resources via your University's proxy server

Through your library

My notes

Similar books and articles

On the Justifiability of ACMG Recommendations for Reporting of Incidental Findings in Clinical Exome and Genome Sequencing.Thomas May - 2015 - Journal of Law, Medicine and Ethics 43 (1):134-142.
Disclosing Secondary Findings from Pediatric Sequencing to Families: Considering the “Benefit to Families”.Benjamin S. Wilfond, Conrad V. Fernandez & Robert C. Green - 2015 - Journal of Law, Medicine and Ethics 43 (3):552-558.
The $1000 Genome: Ethical and Legal Issues in Whole Genome Sequencing of Individuals. [REVIEW]John A. Robertson - 2003 - American Journal of Bioethics 3 (3):35-42.
Whole-Genome Sequencing and Disability in the NICU: Exploring Practical and Ethical Challenges.Michael J. Deem - 2016 - Pediatrics 137 (s1):S47-S55.
Genomic Inheritances: Disclosing Individual Research Results From Whole-Exome Sequencing to Deceased Participants' Relatives.Ben Chan, Flavia M. Facio, Haley Eidem, Sara Chandros Hull, Leslie G. Biesecker & Benjamin E. Berkman - 2012 - American Journal of Bioethics 12 (10):1-8.
Scanning the body, sequencing the genome: Dealing with unsolicited findings.Roel H. P. Wouters, Candice Cornelis, Ainsley J. Newson, Eline M. Bunnik & Annelien L. Bredenoord - 2017 - Bioethics 31 (9):648-656.
Incidental Findings in the Era of Whole Genome Sequencing?Erik Parens, Paul Appelbaum & Wendy Chung - 2013 - Hastings Center Report 43 (4):16-19.
Ethical and legal implications of whole genome and whole exome sequencing in African populations.Galen E. B. Wright, Pieter G. J. Koornhof, Adebowale A. Adeyemo & Nicki Tiffin - 2013 - BMC Medical Ethics 14 (1):21.
Support for Full Disclosure Up Front.Felicitas Holzer & Ignacio Mastroleo - 2015 - Hastings Center Report 45 (1):3-3.
The Role of Whole Genome and Whole Exome Sequencing in Preventive Genomic Sequencing Programs.Gabrielle Bertier, Ma'N. H. Zawati & Yann Joly - 2015 - American Journal of Bioethics 15 (7):22-24.
Comparing the Evolution of CSR Reporting to that of Financial Reporting.Daniel Tschopp & Ronald J. Huefner - 2015 - Journal of Business Ethics 127 (3):565-577.
Is Tone at the Top Associated with Financial Reporting Aggressiveness?Lorenzo Patelli & Matteo Pedrini - 2015 - Journal of Business Ethics 126 (1):3-19.
High‐throughput DNA sequencing – concepts and limitations.Martin Kircher & Janet Kelso - 2010 - Bioessays 32 (6):524-536.
Defining categories of actionability for secondary findings in next-generation sequencing.Celine Moret, Alex Mauron, Siv Fokstuen, Periklis Makrythanasis & Samia A. Hurst - 2017 - Journal of Medical Ethics 43 (5):346-349.
Qualitative thematic analysis of consent forms used in cancer genome sequencing.Clarissa Allen & William D. Foulkes - 2011 - BMC Medical Ethics 12 (1):14.

Analytics

Added to PP
2017-12-22

Downloads
23 (#682,208)

6 months
2 (#1,198,900)

Historical graph of downloads
How can I increase my downloads?

Citations of this work

Add more citations

References found in this work

Add more references